Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) canonically utilizes clathrin-mediated endocytosis (CME) and several other endocytic mechanisms to invade airway epithelial cells. Endocytic inhibitors, particularly those targeting CME-related proteins, have been identified as promising antiviral drugs. Currently, these inhibitors are ambiguously classified as chemical, pharmaceutical, or natural inhibitors. However, their varying mechanisms may suggest a more realistic classification system. Herein, we present a new mechanistic-based classification of endocytosis inhibitors, in which they are segregated among four distinct classes including: (i) inhibitors that disrupt endocytosis-related protein–protein interactions, and assembly or dissociation of complexes; (ii) inhibitors of large dynamin GTPase and/or kinase/phosphatase activities associated with endocytosis; (iii) inhibitors that modulate the structure of subcellular components, especially the plasma membrane, and actin; and (iv) inhibitors that cause physiological or metabolic alterations in the endocytosis niche. Excluding antiviral drugs designed to halt SARS-CoV-2 replication, other drugs, either FDA-approved or suggested through basic research, could be systematically assigned to one of these classes. We observed that many anti-SARS-CoV-2 drugs could be included either in class III or IV as they interfere with the structural or physiological integrity of subcellular components, respectively. This perspective may contribute to our understanding of the relative efficacy of endocytosis-related inhibitors and support the optimization of their individual or combined antiviral potential against SARS-CoV-2. However, their selectivity, combined effects, and possible interactions with non-endocytic cellular targets need more clarification.

The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications

“…Entering virions are exposed to the acidic environment of endosomes within minutes after internalization, and changes in pH can lead to viral penetration. However, in some cases, such as Ebola virus and SARS-CoV [ 125 ], acidic pH alone is not sufficient to induce fusion, and proteolytic cleavage of viral proteins, particularly via cathepsin L and B, is necessary [ 126 , 127 , 128 ].…”

The Long Covid-19 Syndrome the Spike Protein and Stem Cells, the Underrated Role of Retrotransposons, a Working Hypothesis

“…low density (LDL). The scenario suggests that virus mRNAs may eventually encounter the L1 machinery since the L1 elements are generally expressed in different human somatic tissues, including CNS competent cells (glial cells, neuronal progenitor cells, differentiating neurons and mature non-dividing neurons), liver, spleen, adrenal glands, lungs, heart as well as in lymphoblastoid cell lines, platelets, megakaryocyte, and T cells [34][35][36][37].…”

Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity

“…Recently, the world and public health organizations directed resources to curb the outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 and its mutated strains [ 1 – 6 ]. Symptoms of COVID-19 infection included respiratory system complications and severe pneumonia, where patients needed intensive medical care and ventilator treatment [ 5 , 7 , 8 ].…”